methyl 4-[(ethylmethylamino)methyl]-benzoate | 733785-07-4

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: methyl 4-[(ethylmethylamino)methyl]-benzoate
• 英文别名: Methyl4-{[ethyl(methyl)amino]methyl}benzoate；methyl 4-[[ethyl(methyl)amino]methyl]benzoate
• CAS: 733785-07-4
• 化学式: C₁₂H₁₇NO₂
• 分子量: 207.272
• InChiKey: SVRAXIKGSSCXMC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  2.5
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.42
• 拓扑面积：
  29.5
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  methyl 4-[(ethylmethylamino)methyl]-benzoate 在 lithium aluminium tetrahydride 作用下， 以 四氢呋喃 、 正戊烷 为溶剂， 反应 2.0h， 以47.8%的产率得到4-[(ethylmethylamino)methyl]-benzaldehyde
  参考文献：
  名称：

  Design, synthesis and AChE inhibitory activity of indanone and aurone derivatives

  摘要：

  A new series of indanone and aurone derivatives have been synthesized and tested for in vitro AChE inhibitory activity by modified Ellman method. Most of them exhibit AChE inhibitory activities superior to rivastigmine. Further, the most potent compound 1g was selected to evaluate the effect on the acquisition and memory impairment by mice step-down passive avoidance test. (C) 2008 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2008.03.003
• 作为产物：
  描述：

  N-乙基甲基胺 、 4-溴甲基苯甲酸甲酯 以 二氯甲烷 为溶剂， 反应 2.0h， 以54.1%的产率得到methyl 4-[(ethylmethylamino)methyl]-benzoate
  参考文献：
  名称：

  Design, synthesis and AChE inhibitory activity of indanone and aurone derivatives

  摘要：

  A new series of indanone and aurone derivatives have been synthesized and tested for in vitro AChE inhibitory activity by modified Ellman method. Most of them exhibit AChE inhibitory activities superior to rivastigmine. Further, the most potent compound 1g was selected to evaluate the effect on the acquisition and memory impairment by mice step-down passive avoidance test. (C) 2008 Elsevier Masson SAS. All rights reserved.

  DOI：

  10.1016/j.ejmech.2008.03.003

文献信息

• [EN] COMPOUNDS USEFUL AS INHIBITORS OF HELIOS PROTEIN<br/>[FR] COMPOSÉS UTILES COMME INHIBITEURS DE LA PROTÉINE HÉLIOS
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2021101919A1

  公开（公告）日：2021-05-27

  Disclosed are compounds of Formula (I) or a salt thereof, wherein Z is CR6R6 or C=O; Ring A is, and R1, R2, R3, R4, R5, m, and n are defined herein. Also disclosed are methods of using such compounds to inhibit Helios protein, and pharmaceutical compositions comprising such compounds. These compounds are useful in the treatment of viral infections and proliferative disorders, such as cancer.
• Design, synthesis and AChE inhibitory activity of indanone and aurone derivatives
  作者：Rong Sheng、Yu Xu、Chunqi Hu、Jing Zhang、Xiao Lin、Jingya Li、Bo Yang、Qiaojun He、Yongzhou Hu

  DOI：10.1016/j.ejmech.2008.03.003

  日期：2009.1

  A new series of indanone and aurone derivatives have been synthesized and tested for in vitro AChE inhibitory activity by modified Ellman method. Most of them exhibit AChE inhibitory activities superior to rivastigmine. Further, the most potent compound 1g was selected to evaluate the effect on the acquisition and memory impairment by mice step-down passive avoidance test. (C) 2008 Elsevier Masson SAS. All rights reserved.